Analyst Ratings for Novartis (NVS)
NVS Rating Summary
NVS Price Target Summary
- Highest: $180.00 (TD Cowen)
- Lowest: $100.00 (Morgan Stanley)
- Average: $134.28
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$134.28 (-16.1%)
* Over Last 12-Mos
Rating Score: 2.6 / 10
Percentile Rank: 22%
Avg. $ Target:
$134.28 (-16.1%)
* Over Last 12-Mos
Rating Score: 2.6 / 10
Percentile Rank: 22%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/6/2026 | Barclays | Emmanuel Papadakis | Upgrade | Equalweight (Underweight) |
N/A (N/A) |
137.91 (160.12) |
16.1% | Details |
| 11/25/2025 | BofA Securities | Sachin Jain | Upgrade | Buy (Neutral) |
147.42 (134.00) |
127.31 (160.12) |
25.77% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
